-
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
10 Apr 2024 07:09 GMT
… primary and metastatic breast cancers, respectively.81,82 … -positive metastatic breast cancer. Clin Breast Cancer. 2021;21 … anastrozole 1 mg for hormone receptor-positive advanced breast cancer … hormone receptor-positive breast cancer. NPJ Breast Cancer. 2018;4 …
-
Ribociclib Combo Improves iDFS in HR+/HER2– Early Breast Cancer
05 Apr 2024 16:26 GMT
… stage II or III early breast cancer, according to results from … population of patients with early breast cancer,” the study authors wrote. … of patients with early breast cancer who are at increased … orally once daily, or anastrozole was given at 1 mg …
-
Adding ribociclib to endocrine therapy appears to improve invasive disease-free survival in patients with early breast cancer
26 Mar 2024 14:17 GMT
… or to receive NSAI alone (anastrozole). The primary endpoint was … setting for patients with breast cancer though this study does … amongst patients with early-stage breast cancer. Researchers randomly assigned 5101 … 5 mg PO OD or anastrozole 1 mg PO OD) …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 19:10 GMT
… (consisting of either anastrozole, exemestane, letrozole, … receptor-positive metastatic breast cancer.
“Although there … receptor-positive metastatic breast cancer and in biomarker … overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 13:07 GMT
… (consisting of either anastrozole, exemestane, letrozole, … receptor-positive metastatic breast cancer.
“Although there … receptor-positive metastatic breast cancer and in biomarker … overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
UK MFT’s blood test helps determine effectiveness of breast cancer drug
14 Mar 2024 18:16 GMT
… of women eligible for preventative breast cancer drugs.
This highly sensitive hormone … at high risk of developing breast cancer.
According to research, published in … research, anastrozole is now the drug of choice for preventing breast cancer in …
-
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
05 Mar 2024 13:27 GMT
… treatment decisions for breast cancer patients.”
Patients and … the Breast Cancer Index Test
The Breast Cancer Index test … unnecessary treatment. The Breast Cancer Index test has … Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results …
-
Chemotherapy-free regimen induces ‘high’ clinical benefit rate in metastatic breast cancer
25 Feb 2024 18:29 GMT
… at San Antonio Breast Cancer Symposium.
The combination of anastrozole, palbociclib (Ibrance, … positive, HER2-positive metastatic breast cancer includes cytotoxic chemotherapy and HER2 … -positive, HER2-positive metastatic breast cancer.
In phase 1, researchers …
-
NHS medicine shortage warning from pharmacists as epilepsy and breast cancer drugs affected
15 Jan 2024 09:23 GMT
… is used to treat epilepsy. Breast Cancer Now has also spoken about … their hormone treatment including letrozole, anastrozole and tamoxifen. Janet Morrison, the …
-
Managing Forced Menopause Due To Breast Cancer Treatment
10 Jan 2024 21:11 GMT
… As a young hormone-positive breast cancer patient, typical treatment includes … dreaded medical menopause drugs (tamoxifen, anastrozole, letrozole, Lupron).
Most likely, … Your Guide to Navigating Metastatic Breast Cancer Treatments
Weight Gain & …